RxDoctor Payments Data

Gregory Varjabedian, DO

Otolaryngology · Novi, MINPI 1861490856

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 173 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,523, 2.3 times the $666 reported in 2019.

$6,903in general payments, 2019–2025

Across 173 payments — averaging $39.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alk-abello, Inc$1K
  • Integra Lifesciences Corporation$993
  • Acclarent, Inc$820
  • Medtronic$715
  • Intersect ENT, Inc.$641
  • Sanofi$624
  • plus $2K from 15 others

What the payments were for

  • Food & beverage$6,869100%
  • Education$340%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,903 in reported general payments places this provider in the 85th percentile of 257 otolaryngology providers in Michigan.

See all otolaryngology providers in Michigan

Medicare billing

Part B allowed, 2024
$110,928
Medicare patients
569
Services billed
1,584

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl216$5,715
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth43$5,470
Ipratropium Bromide162$4,251
Cevimeline Hcl15$2,175
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip31$1,745
Fluticasone Propionate91$1,517
Cefdinir54$914
Omeprazole50$526
Flunisolide12$511
Famotidine39$500
Clotrimazole18$438
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid26$342
Montelukast Sodium15$254
Methylprednisolone26$126
Mupirocin13$88

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Novi

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →